Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.927
EU - Europa 7.543
AS - Asia 2.398
Continente sconosciuto - Info sul continente non disponibili 32
SA - Sud America 26
OC - Oceania 15
AF - Africa 12
Totale 30.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.566
SE - Svezia 1.452
CN - Cina 1.406
IE - Irlanda 1.240
IT - Italia 1.133
DE - Germania 1.123
UA - Ucraina 1.099
GB - Regno Unito 516
HK - Hong Kong 497
CA - Canada 360
FI - Finlandia 272
RU - Federazione Russa 203
VN - Vietnam 139
FR - Francia 137
IN - India 127
DK - Danimarca 102
TR - Turchia 88
AT - Austria 77
NL - Olanda 62
BE - Belgio 43
JP - Giappone 32
EU - Europa 27
KR - Corea 24
BG - Bulgaria 23
IR - Iran 22
TW - Taiwan 19
SG - Singapore 15
ES - Italia 14
BR - Brasile 13
CH - Svizzera 9
RO - Romania 9
AU - Australia 8
NZ - Nuova Zelanda 7
PL - Polonia 7
PH - Filippine 6
PK - Pakistan 6
CL - Cile 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CO - Colombia 4
CZ - Repubblica Ceca 4
MD - Moldavia 4
MM - Myanmar 4
NO - Norvegia 4
SC - Seychelles 4
GR - Grecia 3
AR - Argentina 2
EG - Egitto 2
MU - Mauritius 2
MY - Malesia 2
OM - Oman 2
TN - Tunisia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
EC - Ecuador 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
ME - Montenegro 1
MX - Messico 1
PT - Portogallo 1
TH - Thailandia 1
UG - Uganda 1
Totale 30.953
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Woodbridge 2.788
Fairfield 2.114
Houston 1.895
Chandler 1.334
Jacksonville 1.212
Dublin 1.204
Ashburn 1.123
Wilmington 992
Seattle 868
Frankfurt am Main 798
Cambridge 769
Dearborn 556
New York 550
Princeton 534
Hong Kong 479
Milan 346
Nanjing 287
Lawrence 227
Altamura 204
Lachine 197
Beijing 158
San Diego 128
Shanghai 115
Boardman 108
Shenyang 82
Guangzhou 80
Andover 76
Nanchang 72
Vienna 71
Toronto 66
Hebei 63
Ottawa 61
Falls Church 57
Helsinki 54
Changsha 53
Hangzhou 51
Jiaxing 50
Tianjin 50
Norwalk 48
Dong Ket 47
Mountain View 45
Fremont 43
Philadelphia 41
London 40
Huizen 36
Jinan 36
Brussels 34
Kunming 34
Lissone 29
Redmond 29
Zhengzhou 29
Chicago 27
Pune 26
San Mateo 26
Auburn Hills 21
Ningbo 20
Plovdiv 20
Leawood 19
Rome 19
Taizhou 18
Tappahannock 16
Washington 16
Edmonton 15
Hefei 15
Nürnberg 15
Padova 14
Boston 13
Fuzhou 13
Los Angeles 13
Montréal 13
Bonndorf 12
Detroit 12
Kilburn 12
Bologna 11
Kiev 11
University Park 11
Hounslow 10
New Haven 10
Tokyo 9
Lanzhou 8
Old Lyme 8
Auckland 7
Mumbai 7
Pisa 7
Yongsan-gu 7
Busto Arsizio 6
Casalserugo 6
Central 6
Groningen 6
Manchester 6
San Martino Di Lupari 6
Shenzhen 6
Singapore 6
Wuhan 6
Bari 5
Bergamo 5
Foggia 5
Foshan 5
Haikou 5
Totale 24.182
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 444
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 351
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 323
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 277
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 234
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 212
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 209
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 199
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 191
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 190
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 190
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 185
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 182
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 180
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 176
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 175
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 173
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 172
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 171
Health Related Quality of Life in the Major Liver Conditions 169
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 169
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 169
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 168
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 168
Foxa1 and Foxa2 regulate bile duct development in mice 167
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 167
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 166
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 166
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 164
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 163
Health related quality of life in chronic liver diseases 163
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 162
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 161
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 161
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 160
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 160
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 159
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 159
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 159
The impact of liver disease on the health-related quality of life 159
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 157
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 157
The challenges of primary biliary cholangitis: What is new and what needs to be done 157
Cholangiocyte biology as relevant to cystic liver diseases 156
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 156
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 156
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 154
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 152
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 151
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 149
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 148
Vascular biology of the biliary epithelium 148
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 148
Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. 147
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 147
The cholangiopathies: disorders of biliary epithelia 147
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice 147
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 147
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 146
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 146
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 146
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 146
Functional anatomy of normal bile ducts 145
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 144
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 143
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 143
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 142
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 142
Notch signaling and new therapeutic options in liver disease 142
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 141
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 141
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 141
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 140
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 140
Liver-allocation policies for patients affected by HCC in Europe 140
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 138
Intracellular pH regulation in isolated rat bile duct epithelial cells 138
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 138
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 138
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 138
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 137
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 137
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 137
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 137
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery 136
Cl(-)-HCO3- exchanger in isolated rat hepatocytes: role in regulation of intracellular pH 136
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism 136
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 136
Emerging concepts in biliary repair and fibrosis 136
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 135
Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis 134
Notch signaling in hepatocellular carcinoma: guilty in association! 134
Epidemiology of unconjugated hyperbilirubinemia: revisited 133
Defective regulation of cholangiocyte Cl-/HCO3- and Na+/H+ exchanger activities in primary biliary cirrhosis 133
Effect of Silybin on biliary lipid composition in rats 133
Inappropriate store-operated cyclic-amp production links altered endoplasmic reticulum (er) ca2 homeostasis to erk/vegf signaling in trpp2-defective cholangiocytes in a mouse model of polycystic liver disease 133
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 133
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 133
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output 132
Totale 16.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.390
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.830 0 0 0 0 0 0 0 0 0 348 713 769
2019/20206.103 807 341 469 523 592 686 814 435 627 288 400 121
2020/20214.303 369 357 442 453 331 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.374 151 142 112 179 505 1.038 764 139 333 11 0 0
Totale 31.949